Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of General Virology|July 19, 2006
Porcine reproductive and respiratory syndrome virus-infected alveolar macrophages contain no detectable levels of viral proteins in their plasma membrane and are protected against antibody-dependent, complement-mediated cell lysisSarah Costers, Peter L Delputte, Hans J Nauwynck
Archives of Virology|June 20, 2008
Porcine reproductive and respiratory syndrome virus modulates apoptosis during replication in alveolar macrophagesSarah Costers, David J Lefebvre, Peter L Delputte, et al.
Vaccine|May 11, 2011
Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodiesMerijn Vanhee, Wander Van Breedam, Sarah Costers, et al.
Veterinary Research|May 19, 2009
Functional impairment of PRRSV-specific peripheral CD3+CD8high cellsSarah Costers, David J Lefebvre, Bruno Goddeeris, et al.
Virus Research|September 15, 2010
GP4-specific neutralizing antibodies might be a driving force in PRRSV evolutionSarah Costers, Merijn Vanhee, Wander Van Breedam, et al.
Archives of Virology|January 7, 2010
GP4 of porcine reproductive and respiratory syndrome virus contains a neutralizing epitope that is susceptible to immunoselection in vitroSarah Costers, David J Lefebvre, Jan Van Doorsselaere, et al.
Viral Immunology|August 18, 2010
A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strainsMerijn Vanhee, Sarah Costers, Wander Van Breedam, et al.
Veterinary Immunology and Immunopathology|April 8, 2011
Porcine reproductive and respiratory syndrome virus (PRRSV)-specific mAbs: supporting diagnostics and providing new insights into the antigenic properties of the virusWander Van Breedam, Sarah Costers, Merijn Vanhee, et al.
Chemsuschem|October 10, 2025
Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO ProjectSándor B Ötvös, Bert Verstappen, Bruno Baillon, et al.
Pageof 1